₹ 6.2 Cr
Volume Transacted
(Nov 22, 2024)
246.9 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Piramal Pharma Ltd
NSE: PPLPHARMA
EPS
₹ 0.44
Last updated on: Nov 22, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Piramal Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 33,130 Cr
EPS
₹ 0.4
P/E Ratio (TTM) *
0.0
P/B Ratio (TTM) *
4.2
Day’s High *
253.3
Day’s Low
₹ 245.2
DTE *
0.6
ROE *
0.7
52 Week High
₹ 307.85
52 Week Low
₹ 114.45
ROCE *
6.4
* All values are consolidated
Last Updated time: 23 Nov 14:30 PM
* All values are consolidated
Last Updated time: 23 Nov 14:30 PM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 249.9 | 246.75 | 253.3 | 245.2 |
21 Nov 2024 | 245.95 | 250.65 | 253.95 | 245 |
19 Nov 2024 | 250.8 | 256 | 259.9 | 248.25 |
18 Nov 2024 | 251.95 | 262.75 | 262.75 | 244.3 |
14 Nov 2024 | 258.4 | 264.45 | 267.1 | 254.45 |
13 Nov 2024 | 259.7 | 249.55 | 277 | 244.75 |
12 Nov 2024 | 250.55 | 267.1 | 269.45 | 248.95 |
11 Nov 2024 | 269.65 | 281.1 | 282.75 | 268.6 |
08 Nov 2024 | 281.8 | 293.1 | 293.55 | 279.25 |
07 Nov 2024 | 292.1 | 295.45 | 303 | 289.35 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 249.9 |
21 Nov 2024 | 245.95 |
19 Nov 2024 | 250.8 |
18 Nov 2024 | 251.95 |
14 Nov 2024 | 258.4 |
13 Nov 2024 | 259.7 |
12 Nov 2024 | 250.55 |
11 Nov 2024 | 269.65 |
08 Nov 2024 | 281.8 |
07 Nov 2024 | 292.1 |
Strength
3
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 33,130
Asset Value
₹ 5,914
4.6 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Piramal Pharma Ltd | 0 | 33,130 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,31,352 |
Divis Laboratories Ltd | 69 | 1,59,265 |
Cipla Ltd | 57 | 1,20,033 |
Torrent Pharmaceuticals Ltd | 51 | 1,07,301 |
Mankind Pharma Ltd | 52 | 1,02,231 |
Historical Market Cap of Piramal Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Piramal Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Piramal Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Piramal Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT
Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...
24 Oct 202412:32
Piramal Pharma to declare Quarterly Result
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...
15 Oct 202410:20
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...
30 Sep 202418:48
Piramal Pharma receives SBTi validation for its GHG commitment
Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...
17 Sep 202410:14
Piramal Pharma grants 48.30 lakh stock options
Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...
26 Jul 202410:05
Piramal Pharma Q1 net loss narrows to Rs 89 crore
Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...
26 Jul 202414:28
Concalls
Unlimited trading at just
Rs. 199*